调控IL-17A/IL-17R通路对脓毒症小鼠远期认知功能的作用

Abstract
Figure/Table
References
Related Citation (2)

Download: PDF (1676 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the effect of regulating IL-17A/IL-17R pathway on long-term cognitive function in mice with sepsis. Methods A mouse model of sepsis was established by cecal ligation and perforation (CLP)In the first part,the experimental mice was divided of 6 groups, SHAM, CLP7, CLP12, CLP9,CLP14,CLP28d, with 5 mice in each group. IL-17A, TNF-α, IL-β were determined by ELISA,Iba-1 and CD11b were detected by immunofluorescence, and the cognitive function of mice was measured by jump test and open field test. In the second part, 80 mice were divided into CLP 14 day intraventricular injection group and CLP 28 day intraventricular injection group. Then the two groups were divided into Sham group, CLP group, Sham+IL-17A group, CLP+IL-17A group, CLP+anti-IL-17A group, CLP+IsotypeA group, CLP+anti-IL-17R group and CLP+IsotypeB group, with 5 animals in each group. According to the groups, the mice were pretreated with recombinant IL-17A, anti-IL-17A antibody, anti-IL-17R antibody, corresponding homologous control antibody or normal saline, and then the changes of cognitive function, the activation level of microglia cells and the levels of pro-inflammatory cytokines were detected. The detection method was the same as that in the first part. Results The first part of the study showed that the levels of inflammatory factors (IL-17A, TNF-α, IL-1β) significantly increased in CLP7d group compared with SHAM group, and the number of central and horizontal crossing grids decreased, the memory latency was shortened, and the cognitive function was significantly impaired. The levels of inflammatory factors (IL-17A, TNF-α, IL-1β) slowly increased from 7 to 28 days, the number of central and horizontal crossing grids decreased, the memory latency was shortened, and the cognitive function continued to decline. The second part showed that compared with CLP group, the levels of inflammatory factors (TNF-α, IL-1β) in CLP14 d and 28 d groups injected with IL-17A significantly increased the number of central and horizontal crossing grids decreased, the memory latency was shortened, and the cognitive function was significantly impaired. However, the levels of inflammatory factors (TNF-α, IL-1β) in CLP14 d and 28 d groups after anti-IL-17A/17R injection significantly decreased, the number of central and horizontal crossing grids increased, the memory latency was prolonged, and the cognitive function was significantly improved, with statistically significant differences among all the groups (P<0.05). Conclusions The level of IL-17A in brain homogenate during sepsis is related to the long-term cognitive dysfunction of sepsis mice. Intervention of IL-17A/IL-17R pathway can inhibit the activation of microglia and reduce the immune inflammatory response in the brain, thereby improving the long-term cognitive dysfunction of sepsis mice.

Key words： sepsis-associated encephalopathy microglia interleukin 17A interleukin 17 receptor neuroinflammation long-term cognition function

Received: 25 September 2023

ZTFLH:

R59

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	DONG Jiaxin
	TAO Tianzhu
	YANG Xiaoming
	HE Xiaofei
	YE Bo

Cite this article:

DONG Jiaxin,TAO Tianzhu,YANG Xiaoming等. Effects of regulating IL-17A/IL-17R pathway on long-term cognitive function in mice with sepsis[J]. Med. J. Chin. Peop. Armed Poli. Forc., 2024, 35(4): 312-317.

URL:

http://journal08.magtechjournal.com/Jwk_wjyx/EN/ OR http://journal08.magtechjournal.com/Jwk_wjyx/EN/Y2024/V35/I4/312

[1]	潘旭升, 丁治国, 陈桂荣, 等. 脓毒症相关性脑病研究进展及展望[J]. 中国中西医结合急救杂志, 2023, 30(4): 507-512.
[1]	潘旭升, 丁治国, 陈桂荣, 等. 脓毒症相关性脑病研究进展及展望[J]. 中国中西医结合急救杂志, 2023, 30(4): 507-512.
[2]	庄欣琪, 谢克亮, 于泳浩, 等. 小胶质细胞与脓毒症脑病的研究进展[J]. 天津医药, 2020, 48(4): 338-342.
[2]	庄欣琪, 谢克亮, 于泳浩, 等. 小胶质细胞与脓毒症脑病的研究进展[J]. 天津医药, 2020, 48(4): 338-342.
[3]	Ye B. Blockade of IL-17A/IL-17R pathway protected mice from sepsis-associated encephalopathy by inhibition of microglia activation[J]. Mediat Inflamm, 2019, 2019(Pt.IV): 8461725.
[3]	Ye B. Blockade of IL-17A/IL-17R pathway protected mice from sepsis-associated encephalopathy by inhibition of microglia activation[J]. Mediat Inflamm, 2019, 2019(Pt.IV): 8461725.
[4]	Gallix B P, Taourel P, Dauzat M, et al. Flow pulsatility in the portal venous system: a study of Doppler sonography in healthy adults[J]. AJR, 1997, 169(1): 141-144.
[4]	Gallix B P, Taourel P, Dauzat M, et al. Flow pulsatility in the portal venous system: a study of Doppler sonography in healthy adults[J]. AJR, 1997, 169(1): 141-144.
[5]	吴健锋. 脓毒症免疫抑制的监测和治疗进展[J]. 中山大学学报(医学科学版), 2020, 41(1): 30-36.
[5]	吴健锋. 脓毒症免疫抑制的监测和治疗进展[J]. 中山大学学报(医学科学版), 2020, 41(1): 30-36.
[6]	Leibovici L. Long-term consequences of severe infections[J]. CMI, 2013, 19(6): 510-512.
[6]	Leibovici L. Long-term consequences of severe infections[J]. CMI, 2013, 19(6): 510-512.
[7]	廖明喻, 刘雪健, 武免免, 等. 脓毒症病理生理机制及治疗新方法的探索[J]. 医学综述, 2019, 25(3): 475-479.
[7]	廖明喻, 刘雪健, 武免免, 等. 脓毒症病理生理机制及治疗新方法的探索[J]. 医学综述, 2019, 25(3): 475-479.
[8]	Yun G. Biology of interleukin-17 and its pathophysiological significance in sepsis[J]. Front Immunol, 2020, 11: 1558.
[8]	Yun G. Biology of interleukin-17 and its pathophysiological significance in sepsis[J]. Front Immunol, 2020, 11: 1558.
[9]	Yang J F, Sundrud M S, Skepner J, et al. Targeting Th17 cells in autoimmune diseases[J]. Trends Pharmacol Sci, 2014, 35(10): 493-500.
[9]	Yang J F, Sundrud M S, Skepner J, et al. Targeting Th17 cells in autoimmune diseases[J]. Trends Pharmacol Sci, 2014, 35(10): 493-500.
[10]	Omid R. A review article on brodalumab in the treatment of moderate-to-severe plaque psoriasis[J]. Immunotherapy, 2017, 9(12): 963-978.
[10]	Omid R. A review article on brodalumab in the treatment of moderate-to-severe plaque psoriasis[J]. Immunotherapy, 2017, 9(12): 963-978.
[11]	Flierl M A, Rittirsch D, Gao H, et al. Adverse functions of IL-17A in experimental sepsis[J]. FASEB, 2008, 22(7): 2198-2205.
[11]	Flierl M A, Rittirsch D, Gao H, et al. Adverse functions of IL-17A in experimental sepsis[J]. FASEB, 2008, 22(7): 2198-2205.
[12]	Wynn J L, Wilson C S, Hawiger J, et al. Targeting IL-17A attenuates neonatal sepsis mortality induced by IL-18[J]. PNAS, 2016, 113(19):E2627-2635.
[12]	Wynn J L, Wilson C S, Hawiger J, et al. Targeting IL-17A attenuates neonatal sepsis mortality induced by IL-18[J]. PNAS, 2016, 113(19):E2627-2635.
[13]	Ogiku M, Kono H, Hara M, et al: Interleukin-17A plays a pivotal role in polymicrobial sepsis according to studies using IL-17A knockout mice[J]. J Surg Res, 2012, 174(1):142-149.
[13]	Ogiku M, Kono H, Hara M, et al: Interleukin-17A plays a pivotal role in polymicrobial sepsis according to studies using IL-17A knockout mice[J]. J Surg Res, 2012, 174(1):142-149.